Regeneron Pharmaceuticals, Inc. revenue breakdown overview

Regeneron Pharmaceuticals, Inc. revenue for the last year amounted to 13.12 B USD, the most of which — 13.12 B USD — came from its highest performing source at the moment, Medicines, the year earlier bringing 12.17 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Regeneron Pharmaceuticals, Inc. 6.75 B USD, and the year before that — 6.82 B USD.